ライフサイエンスコーパス: good manufacturing practice

1 transplant products performed under current Good Manufacturing Practice.

2 recombinant biotherapeutics to standards of good manufacturing practice.

3 n IL-15 (rhIL-15) was produced under current good manufacturing practices.

4 5% were sold by US Web sites and 75% claimed Good Manufacturing Practices.

5 n Escherichia coli and purified according to good manufacturing practices.

6 implementing good agricultural practices and good manufacturing practices and applying existing toxic

7 The process was compliant with Current Good Manufacturing Practices and Current Good Tissue Pra

8 model following current regulatory guidance, good manufacturing practice, and good clinical practice

9 nts for drug approval procedures and current good manufacturing practice, and the FDA has issued a dr

10 II clinical trial evaluating the effects of good manufacturing practice-artesunate in patients with

11 II clinical trial evaluating the effects of good manufacturing practice-artesunate in patients with

12 sions from human volunteers by using Current Good Manufacturing Practice CD16 CliniMACS isolation, la

13 tree by protocols in accordance with current good manufacturing practice (cGMP) and extensively chara

14 iopharmaceuticals is conducted under current good manufacturing practice (cGMP) and involves multiple

15 d vaccine in a manner compliant with current Good Manufacturing Practice (cGMP).

16 cs is challenged by the high cost of current Good Manufacturing Practices (cGMP) production.

17 passages were carried out using U.S. current Good Manufacturing Practices (cGMP) to produce the Vacci

18 ylated cetuximab in conjunction with current good manufacturing practices (cGMP)-grade anti-biotin im

19 Single-step production from a Good Manufacturing Practice cold kit may enable rapid ad

20 n applications such as cell therapies, where good manufacturing practice compatibility is of paramoun

21 a simple, defined, efficient, scalable, and good manufacturing practice-compatible 3D culture system

22 e of PIV3-specific T cells produced with our Good Manufacturing Practice-compliant manufacturing proc

23 The study aims were (1) to develop a Good Manufacturing Practice-compliant method of labeling

24 e results highlight the development of a new Good Manufacturing Practice-compliant platform for gener

25 A practical and current good manufacturing practice-compliant preparation of rad

26 The in vivo properties of good manufacturing practice-compliant, newly developed k

27 plementation of (18)F-UCB-H production under good manufacturing practice conditions and the first hum

28 developed and compiled in a kit system under good manufacturing practice conditions with standardized

29 in 3 validation runs performed under current good manufacturing practice conditions.

30 ET, with (18)F-FDS synthesized using current good manufacturing practice, could rapidly differentiate

31 s study was conducted at a university-based, good manufacturing practice facility and academic ophtha

32 pancreases of those patients at our current good manufacturing practice facility.

33 he iliac crest, and MNCs were separated at a Good Manufacturing Practices facility and administered i

34 ticated ex vivo gene transfer in a dedicated Good Manufacturing Practices facility, limiting availabi

35 art 212 regarding the regulations on current good manufacturing practice for PET drugs.

36 he production of eggs is easily scalable and good manufacturing practices for therapeutics from eggs

37 nd technical components, that we set to meet good manufacturing practice (GMP) and UK regulatory body

38 , about 50 lines have been established under Good Manufacturing Practice (GMP) conditions.

39 Using these markers, we developed a good manufacturing practice (GMP) differentiation protoc

40 This approach, if integrated into a good manufacturing practice (GMP) framework, could resul

41 This Env is currently in good manufacturing practice (GMP) production to be made

42 combined with efficient cryopreservation and good manufacturing practice (GMP)-compatible culture, ma

43 A reference vaccine virus was produced in Good Manufacturing Practice (GMP)-grade facilities in le

44 A reverse genetics, cell-based, Good Manufacturing Practice (GMP)-produced, wild-type A(

45 eerythrocyte-stage protein, we undertook the good manufacturing practices (GMP) manufacture of a reco

46 Seven centers using, and one developing, Good Manufacturing Practices (GMP) processes were survey

47 Successful clinical scale-up in a good manufacturing practices (GMP)-compliant bioreactor

48 A good-manufacturing-practices (GMP) (68)Ge/(68)Ga generat

49 His6 Nanobody and the lead optimized current-good-manufacturing-practice grade analog 2Rs15d were con

50 Clinical-grade DCs were infected with good manufacturing practice-grade ALVAC-HIV vaccine cons

51 om 4 patients with RDEB were transduced with good manufacturing practice-grade retrovirus carrying fu

52 ngle production site operating under typical good manufacturing practice guidelines.

53 erformed on the product according to current good manufacturing practice, including radionuclidic ide

54 l dietary supplements must be produced using good manufacturing practice is an important step toward

55 ese highly purified vaccines, produced under good manufacturing practice-like conditions, to decipher

56 This paves the way for proposed good manufacturing practices manufacture and clinical tr

57 idation set samples were tested with current good manufacturing practices-manufactured reagents after

58 erentiated hESCs using clinically acceptable good manufacturing practices must be developed.

59 In addition, PRINT is a GMP-compliant (GMP=good manufacturing practice) platform amenable for parti

60 of a multistep continuous-flow CGMP (current good manufacturing practices) process that produced 24 k

61 A current Good Manufacturing Practice product of WRSd1 given intra

62 C Env gp145 protein is currently undergoing good manufacturing practice production for use as a reag

63 GMP (Good Manufacturing Practice) production requirements and

64 Good manufacturing practice regulations should be used b

65 s could be generated in chimpanzee plasma by good manufacturing practice using CD14(+) mononuclear pr

66 Adhering to good manufacturing practice, we have developed a new (99

67 supplier, rasa shastra status, and claims of Good Manufacturing Practices were recorded.

68 c stem cells, meeting release criteria under Good Manufacturing Practice, were delivered by endomyoca